Sensitivity [% (95% CI)] before and after Tayside e-alert introduction of ICD-10 code N17 for biochemically defined AKI
| Health board . | Sensitivity before Tayside e-alerts . | Sensitivity after Tayside e-alerts . | Difference in sensitivity . |
|---|---|---|---|
| Tayside | |||
| All stages | 23.7 (22.9–24.5) | 27.9 (27.1–28.8) | 4.27 (4.27–4.28) |
| Stages 2 and 3 | 42.6 (41.1–44.2) | 45.2 (43.5–46.9) | 2.57 (2.56–2.58) |
| Fifea | |||
| All stages | 33.2 (32.3–34.1) | 39.1 (38.0–40.2) | 5.87 (5.87–5.88) |
| Stages 2 and 3 | 51.4 (49.8–53.0) | 57.1 (55.2–59.0) | 5.69 (5.68–5.71) |
| Health board . | Sensitivity before Tayside e-alerts . | Sensitivity after Tayside e-alerts . | Difference in sensitivity . |
|---|---|---|---|
| Tayside | |||
| All stages | 23.7 (22.9–24.5) | 27.9 (27.1–28.8) | 4.27 (4.27–4.28) |
| Stages 2 and 3 | 42.6 (41.1–44.2) | 45.2 (43.5–46.9) | 2.57 (2.56–2.58) |
| Fifea | |||
| All stages | 33.2 (32.3–34.1) | 39.1 (38.0–40.2) | 5.87 (5.87–5.88) |
| Stages 2 and 3 | 51.4 (49.8–53.0) | 57.1 (55.2–59.0) | 5.69 (5.68–5.71) |
There was no intervention in NHS Fife, with AKI e-alerts only implemented in Tayside during the period of analysis. Pre- and post-interventions are for comparison with observed differences in NHS Tayside.
Sensitivity [% (95% CI)] before and after Tayside e-alert introduction of ICD-10 code N17 for biochemically defined AKI
| Health board . | Sensitivity before Tayside e-alerts . | Sensitivity after Tayside e-alerts . | Difference in sensitivity . |
|---|---|---|---|
| Tayside | |||
| All stages | 23.7 (22.9–24.5) | 27.9 (27.1–28.8) | 4.27 (4.27–4.28) |
| Stages 2 and 3 | 42.6 (41.1–44.2) | 45.2 (43.5–46.9) | 2.57 (2.56–2.58) |
| Fifea | |||
| All stages | 33.2 (32.3–34.1) | 39.1 (38.0–40.2) | 5.87 (5.87–5.88) |
| Stages 2 and 3 | 51.4 (49.8–53.0) | 57.1 (55.2–59.0) | 5.69 (5.68–5.71) |
| Health board . | Sensitivity before Tayside e-alerts . | Sensitivity after Tayside e-alerts . | Difference in sensitivity . |
|---|---|---|---|
| Tayside | |||
| All stages | 23.7 (22.9–24.5) | 27.9 (27.1–28.8) | 4.27 (4.27–4.28) |
| Stages 2 and 3 | 42.6 (41.1–44.2) | 45.2 (43.5–46.9) | 2.57 (2.56–2.58) |
| Fifea | |||
| All stages | 33.2 (32.3–34.1) | 39.1 (38.0–40.2) | 5.87 (5.87–5.88) |
| Stages 2 and 3 | 51.4 (49.8–53.0) | 57.1 (55.2–59.0) | 5.69 (5.68–5.71) |
There was no intervention in NHS Fife, with AKI e-alerts only implemented in Tayside during the period of analysis. Pre- and post-interventions are for comparison with observed differences in NHS Tayside.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
